These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The efficacy of intravenous pulse cyclophosphamide in the treatment of severe lupus nephritis in children. Tangnararatchakit K; Tapaneya-Olarn C; Tapaneya-Olarn W J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S104-10. PubMed ID: 10730528 [TBL] [Abstract][Full Text] [Related]
24. Beyond immunosuppression - challenges in the clinical management of lupus nephritis. Masood S; Jayne D; Karim Y Lupus; 2009 Feb; 18(2):106-15. PubMed ID: 19151111 [TBL] [Abstract][Full Text] [Related]
25. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure. Faurschou M; Starklint H; Halberg P; Jacobsen S J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113 [TBL] [Abstract][Full Text] [Related]
26. Treatment for lupus nephritis: a revisit. Lai KN; Tang SC; Mok CC Nephrology (Carlton); 2005 Apr; 10(2):180-8. PubMed ID: 15877679 [TBL] [Abstract][Full Text] [Related]
27. Lupus nephritis. Sauter M; Anders HJ Minerva Med; 2007 Dec; 98(6):749-58. PubMed ID: 18299686 [TBL] [Abstract][Full Text] [Related]
28. Therapeutic options for critically ill patients suffering from progressive lupus nephritis or Goodpasture's syndrome. Merkel F; Netzer KO; Gross O; Marx M; Weber M Kidney Int Suppl; 1998 Feb; 64():S31-8. PubMed ID: 9475486 [TBL] [Abstract][Full Text] [Related]
29. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment. Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087 [TBL] [Abstract][Full Text] [Related]
30. The Euro-Lupus Nephritis Trial: the development of the sequential treatment protocol. D'Cruz DP; Houssiau FA Lupus; 2009 Sep; 18(10):875-7. PubMed ID: 19671785 [TBL] [Abstract][Full Text] [Related]